George Dudnik, 36, was diagnosed with stage four ROS1-positive lung cancer in November after being told he was 'too young and ...
George Dudnik, 36, was told he was far too young and fit to be diagnosed with cancer – but after a series of terrifying ...
In October, a CT scan unveiled several troublesome spots in his right lung, and a subsequent surgery in November left him ...
During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...
George Dudnik was diagnosed with stage four lung cancer in November – and was told he would die from it despite being ...
Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo Oviedo-Mori survive — and thrive — with advanced lung cancer for 15 years.
Immutep (ASX:IMM) has dosed the first patient in its pivotal Phase III trial evaluating eftilagimod alfa (efti) for the ...
An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...
A fit and healthy young man has been told he has incurable cancer after an initial frightening warning sign. George Dudnik, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results